✨ Your Portfolio is fetched and updated from zerodha.

Abbott India Ltd.

ABBOTINDIA

Market Cap
₹60,844 Cr.
P/E
47.36

Abbott India Ltd.

  • Abbott India
  • Alkem Laboratories
  • Aurobindo Pharma
  • TJI Pharma
FAQs on Abbott India Ltd. Shareprice

Abbott India has given better returns compared to its competitors.
Abbott India has grown at ~16.04% over the last 4yrs while peers have grown at a median rate of 10.25%

Abbott India is expensive when considering the EV/EBIDTA, however latest PE is < 3 yr avg PE.
Latest PE of Abbott India is 47.08, while 3 year average PE is 50.35.
Also latest EV/EBITDA of Abbott India is 38.38 while 3yr average is 36.55.

View FAQ's On Business
Growth Table
  • Abbott India Ltd.
  • Alkem Laboratories
  • Aurobindo Pharma
Balance Sheet
  • Abbott India Ltd.
  • Alkem Laboratories
  • Aurobindo Pharma
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Abbott India Ltd.
  • Alkem Laboratories
  • Aurobindo Pharma
Cash Flow
  • Abbott India Ltd.
  • Alkem Laboratories
  • Aurobindo Pharma
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Abbott India Ltd.
  • Alkem Laboratories
  • Aurobindo Pharma
Quarterly Results
  • Abbott India Ltd.
  • Alkem Laboratories
  • Aurobindo Pharma
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Rhapson method.
Learn how to use Reverse DCF
FAQs on Abbott India Ltd. Financials

Balance sheet of Abbott India is strong.
It shouldn't have solvency or liquidity issues.

Yes, The debt of Abbott India is increasing.
Latest debt of Abbott India is -₹1,105.7 Crs as of Sep-24.
This is greater than Mar-24 when it was -₹4,268.98 Crs.

Yes, profit is increasing.
The profit of Abbott India is ₹1,285 Crs for TTM, ₹1,201 Crs for Mar 2024 and ₹949 Crs for Mar 2023.

The company seems to pay a good stable dividend.
Abbott India latest dividend payout ratio is 72.53% and 3yr average dividend payout ratio is 72.81%

Companies resources are majorly tied in miscellaneous assets

View FAQ's On Shareholding
timeline Timeline
watchlist Watchlist
portfolio Portfolio
alerts Alerts
filter Research
filter Stock Screener
markets Market
raw materials Raw Material
Data feed provided by Accord Fintech